Skip to main navigation Skip to search Skip to main content

Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig

  • PCAWG Evolution and Heterogeneity Working Group
  • , PCAWG Consortium
  • University of Toronto
  • Vector Institute
  • The Francis Crick Institute
  • University of Oxford
  • Wellcome Trust Genome Campus
  • Broad Institute
  • European Molecular Biology Laboratory
  • University of Texas MD Anderson Cancer Center
  • Cancer Research UK Cambridge Institute
  • Oregon Health and Science University
  • Dana-Farber Cancer Institute
  • Harvard University
  • Ontario Institute for Cancer Research
  • University of California at Los Angeles
  • Peter Maccallum Cancer Centre
  • University of Melbourne
  • Cambridge University Hospitals NHS Foundation Trust
  • University of Cambridge
  • Walter and Eliza Hall Institute of Medical Research
  • University of Cologne
  • KU Leuven
  • Simon Fraser University
  • Vancouver Prostate Centre
  • Berlin Institute of Health at Charité – Universitätsmedizin Berlin
  • German Cancer Research Center
  • Heidelberg University 
  • Massachusetts General Hospital
  • Cornell University
  • New York Genome Center
  • University of Ljubljana
  • NorthShore University HealthSystem
  • The University of Chicago
  • University of California at Santa Cruz

Research output: Contribution to journalArticlepeer-review

34 Citations (Scopus)

Abstract

The type and genomic context of cancer mutations depend on their causes. These causes have been characterized using signatures that represent mutation types that co-occur in the same tumours. However, it remains unclear how mutation processes change during cancer evolution due to the lack of reliable methods to reconstruct evolutionary trajectories of mutational signature activity. Here, as part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, which aggregated whole-genome sequencing data from 2658 cancers across 38 tumour types, we present TrackSig, a new method that reconstructs these trajectories using optimal, joint segmentation and deconvolution of mutation type and allele frequencies from a single tumour sample. In simulations, we find TrackSig has a 3–5% activity reconstruction error, and 12% false detection rate. It outperforms an aggressive baseline in situations with branching evolution, CNA gain, and neutral mutations. Applied to data from 2658 tumours and 38 cancer types, TrackSig permits pan-cancer insight into evolutionary changes in mutational processes.

Original languageEnglish
Article number731
JournalNature Communications
Volume11
Issue number1
DOIs
Publication statusPublished - 1 Dec 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

OECD Field of Science

  • 3. Medical and Health Sciences

Fingerprint

Dive into the research topics of 'Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig'. Together they form a unique fingerprint.

Cite this